Stay updated on Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.

Latest updates to the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page
- Check4 days agoChange DetectedThe page revision indicator has been updated from v3.5.3 to v3.5.4, representing a minor update to the page's version. This does not alter the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s revision/version indicator at the bottom was updated from v3.5.2 to v3.5.3, reflecting a website software update without changing the underlying study details.SummaryDifference0.1%

- Check33 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 has been added. The previous notices, including the funding-lapse notice and Revision: v3.4.1, have been removed.SummaryDifference0.5%

Stay in the know with updates to Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.